Literature DB >> 2092970

Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.

R Fariello1, C Dal Palu, A Pessina, A Semplicini, A Pirrelli, V Vulpis, R Carretta, G Bellini, R Buoninconti, W Wurst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2092970     DOI: 10.2165/00003495-199000404-00017

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

Review 2.  Basic pharmacology of alpha-adrenoceptor antagonists and hybrid drugs.

Authors:  P A van Zwieten
Journal:  J Hypertens Suppl       Date:  1988-12

3.  Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.

Authors:  J Rosenthal; R Haerlin
Journal:  J Hypertens Suppl       Date:  1988-12

4.  Initial antihypertensive drug therapy: alpha blocker or diuretic. Interim report of a randomized, controlled trial.

Authors:  R Stamler; J Stamler; F C Gosch; D M Berkson; A Dyer; P Hershinow
Journal:  Am J Med       Date:  1986-02-14       Impact factor: 4.965

5.  Initial antihypertensive therapy. Comparison of prazosin and hydrochlorothiazide.

Authors:  M H Alderman; T K Davis; L Carroll
Journal:  Am J Med       Date:  1986-02-14       Impact factor: 4.965

  5 in total
  2 in total

Review 1.  Urapidil. A reappraisal of its use in the management of hypertension.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

2.  Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

Authors:  J P Baguet; B Legallicier; P Auquier; S Robitail
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.